Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 149   

Articles published

BMY 51.12 +0.11 (0.22%)
price chart
Bristol-Myers Squibb Co (NYSE:BMY): EU Approval For Eliquis And 1H14 ...
Boston, MA - (NYSEPOST) - 07/30/2014 - Bristol-Myers Squibb Co (NYSE:BMY) recently announced that its portfolio candidate Eliquis has received the European Commission approval for multiple clinical indications including, Pulmonary Embolism - PE, ...
EC approves label expansion for Eliquis  Seeking Alpha (registration)
Company Update (NYSE:BMY): European Commission Approves Eliquis ...  Jutia Group
Related articles »  
Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc.
The Federal Circuit affirmed a judgment by the United States District Court for the District of Delaware invalidating clam 8 of U.S.
This month in 1989: the creation of Bristol-Myers Squibb
It was also in this particular period on July 28, 1989, that two US companies agreed to form what would become at the time the world's second biggest pharma company - Bristol-Myers Squibb (BMS). The stock-swap merger between Bristol-Myers and Squibb ...
Bristol-Myers Squibb Company (BMY) Highlighted As Storm The Castle Stock
Bristol-Myers Squibb's �Neutral� Rating Reaffirmed at Zacks (BMY)  Mideast Time
Related articles »  
Bristol-Myers Squibb Popular Amongst Latest 13F Filers
At Holdings Channel, we have reviewed the latest batch of the 30 most recent 13-F filings for the 06/30/2014 reporting period, and noticed that Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY) was held by 14 of these funds.
Bristol-Myers Squibb Co (BMY) Releases FY14 Earnings Guidance
Bristol-Myers Squibb logo Bristol-Myers Squibb Co (NYSE:BMY) updated its FY14 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $1.70-1.80 for the period, compared to the Thomson Reuters consensus ...
Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic ...
NEW YORK, NY, USA & OSAKA, Japan I July 23, 2014 I Bristol-Myers Squibb Company(NYSE:BMY) andOno Pharmaceutical Co., Ltd.
BioMed Realty And Bristol-Myers Squibb Sign Lease To Expand Relationship To ...  MarketWatch
UPDATE 2-Bristol-Myers profit tops forecasts, helped by newer drugs  Reuters UK
Related articles »  
Bristol-Myers Squibb Announces Plans for Third Quarter Submission of a ...
PRINCETON, N.J., Jul 10, 2014 (BUSINESS WIRE) -- Bristol-Myers Squibb Company (NYSE:BMS) today announced that, following discussions with the U.S.
Bristol-Myers Squibb To File Biologics Licensing Application For Opdivo In Q3  NASDAQ
Bristol-Myers Squibb Selects GEP To Provide Strategic Category Management ...  Businessweek
Related articles »  
Monday's Hot Stocks: Bristol-Myers Squibb Company (NYSE:BMY), VirnetX ...
Bristol-Myers Squibb Company (NYSE:BMY) second quarter 2014 earnings (excluding special items and the diabetes business divested earlier in the year) of 46 cents per share beat the Zacks Consensus Estimate by 2 cents.
Bristol-Myers Squibb Rating Reiterated by Zacks (BMY)
Bristol-Myers Squibb Co logo Bristol-Myers Squibb (NYSE:BMY)'s stock had its �neutral� rating restated by Zacks in a report issued on Friday.
Bristol-Myers Squibb PT Raised to $34.00 at MKM Partners (BMY)
Bristol-Myers Squibb Co logo Research analysts at MKM Partners upped their price target on shares of Bristol-Myers Squibb (NYSE:BMY) from $29.00 to $34.00 in a report released on Friday.